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Abstract: As Streptomyces have shown an outstanding capacity for drug production, different
campaigns in geographically distant locations currently aim to isolate new antibiotic producers.
However, many of these newly isolated Streptomyces strains are classified as identical to already
described species. Nevertheless, as discrepancies in terms of secondary metabolites and morphology
are possible, we compared two Streptomyces strains with identical 16S rRNA gene sequences but
geographically distant origins. Chosen were an Easter Island Streptomyces isolate (Streptomyces sp.
SN25_8.1) and the next related type strain, which is Streptomyces griseus subsp. griseus DSM 40236T
isolated from Russian garden soil. Compared traits included phylogenetic relatedness based on
16S rRNA gene sequences, macro and microscopic morphology, antibiotic activity and secondary
metabolite profiles. Both Streptomyces strains shared several common features, such as morphology
and core secondary metabolite production. They revealed differences in pigmentation and in the
production of accessory secondary metabolites which appear to be strain-specific. In conclusion,
despite identical 16S rRNA classificationStreptomyces strains can present different secondary metabolite
profiles and may well be valuable for consideration in processes for drug discovery.
Keywords: Streptomyces; geographical isolation; Easter Island; secondary metabolites; 16S rRNA;
morphology; High Resolution Mass Spectroscopy (HRMS); Nuclear Magnetic Resonance (NMR);
horizontal gene transfer
1. Introduction
The increasing number of pathogens that show antibiotic resistance has triggered the
bioprospection of new antibiotics [1]. Actinobacteria have shown to be an exceptional source of
new antibiotics and pharmaceuticals in general [2]. Within the Actinobacteria phylum, Streptomyces is
the most prolific drug producing genus [3]. Streptomyces species have shown an outstanding capacity
for the production of secondary metabolites, many of which effectively can treat human diseases.
Secondary metabolites of Streptomyces species belong to different classes of compounds, such as:
polyketides [4], peptides [5] and polyketide-peptides hybrids [6], and have been characterized with
different biological activities, such as: antibacterial [7] antifungal [8], anticancer [9] and immune
suppression [10].
Microorganisms 2019, 7, 166; doi:10.3390/microorganisms7060166 www.mdpi.com/journal/microorganisms
Microorganisms 2019, 7, 166 2 of 15
Biogeographically, Streptomyces species have a wide distribution, since they can be found in
the most diverse habitats, like polar territories [11], deserts [12], highlands [13], insects [14], marine
invertebrates [15] and marine sediments [16,17].
As a result of the current drug bioprospection, multiple Streptomyces strains are isolated every
year, however only a limited percentage of these bacteria represent new species [18]. Most of them
represent already characterized species displaying similar or even identical phylogenetic features [19].
The most widely used method of bacterial characterization is the analysis of the 16S rRNA gene
sequence which despite its utility and quickness, has shown ambiguity when discriminating closely
related Streptomyces strains (>99% of similarity) [20]. Often known Streptomyces species are considered
to be of little significance for drug discovery due to their lack of novelty in terms of phylogeny and
physiology. In consequence, drug discovery may overlook new metabolites produced from Streptomyces
strains which are closely related to already known strains since they are assumed to be producers of
identical secondary metabolites [21]. However, investigations have shown that in addition to the core
secondary metabolites, many Streptomyces strains have an accessory chemical arsenal which has not
been completely studied [22]. Moreover, diverse experiments have demonstrated that changing culture
conditions of Streptomyces strains may activate cryptic biosynthetic pathways, producing uncommon
or unknown strain-specific metabolites [23,24].
The advancement in genome sequencing and the reduction of its cost has allowed the differentiation
of closely related Streptomyces species at the genomic level [25] and has shed light about the unexploited
cryptic biosynthetic pathways harbored by Streptomyces strains, or bacteria in general [26]. Despite the
genomic advancement, we still lack the understanding of expression and regulation of biosynthetic
pathways [26]. This makes it necessary to perform an in vitro characterization of Streptomyces strains
to obtain specific information of their secondary metabolite features.
To date, few efforts have been made to thoroughly evaluate the differences in secondary metabolite
production between two Streptomyces strains that are identical according to 16S rRNA phylogeny but
originate from different geographic regions [19].
Therefore, we compared two phylogenetically identical Streptomyces strains, an isolate from a
marine sediment sample from Easter Island, a remote location in the middle of the South Pacific Ocean,
and as counterpart a reference strain isolated from Russian garden-soil. Our data showed that the
phylogenetically almost identical Streptomyces strains shared a number of morphological and chemical
features as widely recognized and also expected. However, we also found striking differences in the
accessory metabolites produced, which appear to be strain specific. We suggest that these chemical
differences may have risen through niche specialization, as well as horizontal gene transfer.
2. Materials and Methods
2.1. Streptomyces Strains
Streptomyces sp. SN25_8.1 was obtained from a marine sediment sample which was collected
from the coastal zone of the Easter Island, Chile (27◦08′45.0” S, 109◦25′49.8” W), by the first author
(Chilean citizen), in March 2016. The sampling site was outside of the Isla de Pascua national park,
and the sample was taken in agreement with regulations by the Chilean government. Streptomyces
griseus subsp. griseus DSM 40236T was obtained from the German Collection of Microorganisms and
Cell Cultures GmbH (DSMZ). This strain was isolated by Krainsky from a garden soil sample from
Russia [27,28].
2.2. Culture Conditions
Cultivation and morphological comparison of the of Streptomyces strains were made using solid
Glucose-Yeast extract-Malt extract medium (GYM), 4 g glucose × H2O, 4 g yeast extract, 10 g malt
extract, 2 g CaCO3, 15 g agar, 1 L deionized water, and pH 7.2 [29].
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For the evaluation of the secondary metabolites production, the Streptomyces strains were grown
in Ultra Yield®flasks 2.5 L (Thomson, Oceanside, CA, USA), which contained 1 L of slightly modified
Starch-Glucose-Glycerol (SGG) liquid medium [30]. The composition of the production medium was:
5 g soluble starch, 5 g glucose x H2O, 5 g glycerol, 1.25 g cornsteep powder, 2.5 g peptone from soymeal,
1 g yeast extract, 1.5 CaCO3, and 1 L deionized water. The medium was also supplemented with 15 g/L
Tropic Marin™ salt (Wartenberg, Germany). The pH was adjusted to 7.7 using 1 M of HCl and NaOH.
The culture was kept in orbital agitation at 240 rpm, 28 ◦C, for 14 days in darkness.
2.3. Molecular Characterization and Phylogenetic Analysis
DNA was extracted from the bacterial cells through the use of DNA isolation kit, DNeasy™
(Qiagen, Hilden, Germany), following the manufacturer instructions. Subsequently, the amplification
of the 16S rRNA gene sequence was performed with PCR and the use of general bacterial primers in a
concentration of 10 pmol/µL, i.e. 27f, 1492r [31,32], 1387r [33] and 1525r [34].
PCR reagents were obtained from GE Healthcare illustra™ PuReTaq Ready-To-Go™ PCR Beads
(GE Healthcare, Glattbrugg, Switzerland) containing DNA polymerase, MgCl2, and dNTPs. The PCR
conditions were the same as reported by Staufenberger et al. [32]. The 16S rRNA genes were sequenced
at the Center for Molecular Biosciences (ZMB) at Kiel University using the primers 27f [31], 342f [32],
534r [32] and 1525r [34]. The 16S rRNA gene sequences were manually curated using Chromas
pro software, version 1.7.6 (Technelysium Pty Ltd, Tewantin QLD, Australia) and saved in FASTA
format. Primary phylogenetic characterization of the Streptomyces strains was achieved using nucleotide
NCBI-BLAST and EZbioCloud [35]. Subsequently, the obtained sequences were standardized according
to the global SILVA alignment for rRNA genes [36]. This primary alignment was visually compared
using ExPASy (SIB bioinformatics resource portal) [37] to determine the level or similarity or divergence
of both Streptomyces 16S rRNA gene sequences. For the construction of a Streptomyces phylogenetic
tree, we retrieved the next related type strains 16S rRNA gene sequences from NCBI. All the 16S rRNA
gene sequences were gathered in a single FASTA file and aligned in SINA-SILVA web platform [36].
The outcome of SINA gave a multi-aligned Streptomyces sequences FASTA file which was processed
with MEGA [38] to delete gap sites, and subsequently to run bootstrapped phylogenetic trees, using
neighbor joining model.
2.4. Morphological Analysis
Three week-old plates of Streptomyces cultures on solid GYM medium were inspected and recorded
under a stereo microscope (SZX16, Olympus, Japan), using a visual increase of 0.7-fold. Additionally,
cells and spores of both Streptomyces strains were inspected under an Axiophot microscope using a
100x lens and recorded with Axio Cam MRm (Zeiss, Göttingen, Germany).
2.5. Chemical Analysis
After the growth period, 20 g/L of amberlite XAD-16 (Sigma-Aldrich, St. Louis, MO. USA) were
added to each culture flask and mixed for one hour using orbital agitation in 120 rpm. Subsequently,
the resin was separated through cheesecloth filtration [39], and the liquid was discarded. Amberlite
was mounted on a glass funnel, and washed with 3 L of deionized water, and eluted with 1 L of
acetone [39]. Acetone was then concentrated under reduced pressure until obtaining an aqueous
residue. Subsequently, 1 L of deionized water was added to the acetone residue and brought to a
separation funnel. To extract the organic molecules, 3 × 300 mL of ethyl acetate was used. The organic
phase was concentrated under reduced pressure until dryness.
Streptomyces secondary metabolite profiles were acquired through high pressure liquid
chromatography (HPLC, Merck-Hitachi, Darmstadt, Germany) coupled with evaporative light
scattering detector (ELSD, Sedere, Olivet, France). The secondary metabolites profiling was developed
primarily as screening strategy, using 30 min gradient. The gradient developed was as following:
0 min: 90% water, 10% acetonitrile, 20 min: 0% water, 100% acetonitrile, 23 min: 0% water, 100%
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acetonitrile, 28 min: 90% water, 10% acetonitrile, 30 min: 90% water, 10% acetonitrile. The used column
was reverse phase C18 gravity SB™ (Macherey-Nagel, Düren, Germany). The wavelengths recorded
were 210 and 254 nm. Dereplication process and 254 nm HPLC profiling were made with a High
Resolution Liquid Chromatography coupled with Mass Spectroscopy (HRLCMS), Thermo Scientific™
UltiMate 3000 RS UHPLC coupled to a Thermo Scientific™ Q Exactive™ Hybrid-Quadrupol-Orbitrap
MS (Thermo, Bremen, Germany), positive mode, and a 35 minutes gradient of H2O and acetonitrile
supplemented with 0.1% of formic acid. The gradient developed was as following: 0 min: 90% water,
10% acetonitrile, 25 min: 0% water, 100% acetonitrile, 28 min: 0% water, 100% acetonitrile, 30 min: 90%
water, 10% acetonitrile, 35 min: 90% water, 10% acetonitrile. The used column was reverse phase C18
gravity SB™ (Macherey-Nagel, Düren, Germany). The wavelength recorded was 254 nm. Mass and
spectral data were evaluated with Xcalibur®(Thermo Scientific, San Jose, CA, USA), and compared
with online databases (MarinLit, and Scifinder), and literature.
1H Nuclear Magnetic Resonance (NMR) experiments of the crude extracts were acquired to
characterize the main components. The samples were dissolved in deuterated chloroform (Eurisotop™,
Saint-Aubin, France), and transferred to NMR tubes (178 × 5.0 mm). Experiments were acquired on
a Bruker Avance III spectrometer (Rheinstetten, Germany) operating at 600 MHz proton frequency
equipped with a cryogenically cooled triple resonance z-gradient probe head using stand pulse
sequences from the Bruker experiment library. Spectra were referenced against tetramethylsilane (TMS)
as internal standard. NMR data was analyzed with TopSpin (version 3.5.b.91 pl 7, Bruker BioSpin Ltd.,
Karlsruhe, Germany).
2.6. Antibiotic Activity
The disc diffusion method was used to determine the antibiotic activity [40]. Thus, crude extracts
obtained from the Streptomyces strains were tested to determine their activity on Gram-positive and
Gram-negative bacteria. For this purpose, we chose Staphylococcus lentus DSM 20352, and Escherichia coli
DSM 498. These bacteria were cultured in TSB medium (17 g of peptone from casein, 3 g peptone
from soymeal, 2.5 g glucose × H2O, 5 g NaCl, 2.5 g K2HPO4, 1 L deionized water and pH to 7.3) at
37 ◦C for 24 h. Crude extracts were dissolved in MeOH to be subsequently transferred to a paper
disc to reach a final concentration of 50 µg per disc. Additionally, we used an antibiotic susceptibility
disc of streptomycin (Oxoid®, Columbia, MD, USA) as a positive indicator of antibiotic activity in a
concentration of 25 µg per disc. All the used paper discs had a diameter of 6 mm. The plates were
inoculated with fresh culture of S. lentus DSM 20352, and E. coli DSM 498, and incubated at 37 ◦C for
24 h. After the incubation period, the inhibition zone was measured and registered.
3. Results
3.1. Phylogenetic Analysis
Molecular characterization of both Streptomyces strains was performed with the sequence of the
16S rRNA gene as a genetic marker. The amplification and subsequent characterization resulted in
nearly complete 16S rRNA sequences, whereby the Easter Island strain, Streptomyces sp. SN25_8.1,
revealed a sequence with 1477 nucleotides (NCBI access# MK734066) compared to the sequence of
the laboratory grown type strain of Streptomyces griseus subsp. griseus DSM 40236T, with a sequence
of 1476 nucleotides (NCBI access# MK734067). We used the new sequence of the 16S rRNA gene of
the type strain, Streptomyces griseus subsp. griseus DSM 40236T, for detailed sequence comparison,
since the publicly available sequence dates to 2003 (NCBI access# AY207604). Both the new and old
sequences are identical.
The alignment of the 16S rRNA gene sequences of strains DSM 40236T (from a Russian garden
soil sample) and SN25_8.1 (from Easter Island) showed that the strains shared identical sequences of
the 16S rRNA gene (Supplementary Figure S1). The phylogenetic tree (Figure 1) revealed, that both
strains affiliate to one cluster, which is separated from the other Streptomyces spp. strains.
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parenthesis. * Streptomyces griseus subsp. griseus DSM 40236T LAB COLL: Sequence experimentally 
obtained from fresh cultures and deposited in NCBI (MK734067). ** Streptomyces griseus subsp. griseus 
DSM 40236T: Sequence retrieved from NCBI (M76388). The evolutionary distances were computed 
using the Jukes-Cantor method and are in the units of the number of base substitutions per site (scale). 
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3.2. Morphological Comparison 
After cultivation of the strains in solid GYM medium for three weeks, we continued with a 
morphological comparison of the Easter Island Streptomyces sp. SN25_8.1 and the type strain, 
Streptomyces griseus subsp. griseus DSM 40236T (Figure 2). The visual comparison showed evident 
macroscopic differences between the strains, such as; spore pigmentation, amount of spore 
formation, and aerial hyphae distribution on the colony. Light microscopic examination of the cells 
and spores of both strains showed no differences. Nevertheless, a detailed characterization of the 
spores and spore-bearing hyphae would require scanning electron microscopy. 
Figure 1. Phylogenetic characterization of the Streptomyces strains using a neighbor joining model.
Light blue: experimentally compared Streptomyces strains. Bootstrap = 1000; Bootstrap values are
shown on the branch, where 100 is maximum; T: type strain; NCBI access number is within parenthesis.
* Streptomyces griseus subsp. griseus DSM 40236T LAB COLL: Sequence experimentally obtained
from fresh cultures and deposited in NCBI (MK734067). ** Streptomyces griseus subsp. griseus DSM
40236T: Sequenc retrieved from NCBI (M76388). The evolutionary distances were computed using
the Jukes-Cantor method and are in the units of the number f base ubstitutions per site (scale).
The analysis involved 31 nucleotide sequences. All positions containing gaps and missing data were
eliminated. There were a total of 1338 positions in the final dataset.
3.2. Morphological Comparison
After cultivation of the strains in solid GYM medium for three weeks, we continued with
a morphological comparison of the Easter Island Streptomyces sp. SN25_8.1 and the type strain,
Streptomyces griseus subsp. griseus DSM 40236T (Figure 2). The visual comparison showed evident
macroscopic differences between the strains, such as; spore pigmentation, amount of spore formation,
and aerial hyphae distribution on the colony. Light microscopic examination of the cells and spores
of both strains showed no differences. Nevertheless, a detailed characterization of the spores and
spore-bearing hyphae would require scanning electron mi roscopy.
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some metabolites but differ in the production of others. 
Figure 2. Comparison of cell and colony morphology of the two Streptomyces strains after growth on
GYM medium for three weeks. Photos were recorded using a stereo microscope (upper figures) and
microscope with a 100x lens (bottom figures).
3.3. Secondary Metabolites Production
Both Streptomyces strains produced different metabolites patterns and quantities after growth in
a Starch-Glucose-Glycerol medium (slightly modified SGG). Streptomyces sp. SN25_8.1 produced a
total of 60.9 mg of crude extract, while the type strain Streptomyces griseus subsp. griseus DSM 40236T
produced almost th double amount, 108.1 mg. The HPLC chromatograms of the crud extracts s owed
differences and similarities b tween the two Streptomyces strains (Figure 3A,B). The similarities found in
the chro atograms (taking the Easter Island representative as a point of comparison, Figure 3B) were
observed in the following retention time (RT): 5.8, 8.5, 9.33, 9.54, 11.0, 11.5, 12.0, 12.4, 13.1, 15.3, 16.0 and
18.8 min. The observed peak at RT 27.3 min is a methodic artifact and should not be considered in the
comparison of the chromatograms. Differences were found between the chromatograms at RT 3.1, 4.5,
5.3, 7.2, 11.3, 11.6, 13.7, and 18.46. Considering this information, it is fair to state that these Streptomyces
strains differ significantly, because they share some metabolites but differ in the production of others.
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Figure 3. HPLC metabolite profile co i f Streptomyce sp. SN25_8.1 from Easter Isl ,
and treptomyces griseus subsp. griseus DSM 40236T from Russia, measured at 254 nm (A,B), and
1H NMR comparison of the crude extract of both strains (C, ). CDCl3: deuterated chloroform;
TMS: tetramethylsilane.
In order to extend the previous HPLC data, 1H NMR experiments were performed to again display
similarities as well as differences among the ost abundant chemical groups present in both samples
(Figure 3C,D). For example, remarkable similarities were found in the aromatic proton zone (7–8 ppm),
in the olefinic proton zone (of 4–6, ppm), and in the low frequency region (1.0–3.5 ppm), where
aliphatic methyl, methylenes and methines are commonly found. However, abundant differences
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between the two spectra are apparent for example in the high frequency protons around 12.2–12.4 ppm,
the broad peaks close to 8 ppm, olefinic signals around 5.5 ppm, and the methyl protons around
0.65 ppm. Further, in particular the strongly differing intensities in the mentioned regions suggest also
the presence of large differences in the relative metabolite contributions in these mixtures.
As simple one-dimensional 1H NMR profiles do not allow for a compound identification,
attempts to identify some of the mixture components by high resolution LC-MS techniques (HRLCMS)
were undertaken. Several molecules could be identified in both Streptomyces representatives based
on their exact masses and a chemical database search (Supplementary Materials). We observed
that the two Streptomyces strains had a core chemical arsenal that is shared by both strains and
an accessory chemical arsenal which seems to be strain specific (Figure 4). The identified core
chemicals comprised gancidin W, YF-0200-R-B, emycin E, phenatic acid, netropsin, actiphenol,
6-beta-deoxy-5-hydroxy-tetracycline and TMC-86B. From the analysis of the accessory metabolites,
we observed that the Easter Island representative, Streptomyces sp. SN25_8.1, produced seven
detectable chemicals, which were: albidopyrone, cyclizidine, epithienamycin C, cycloheximide,
SF-733C, protomycin and N-Valyldihidroxyhomoproline, as accessory metabolites. In contrast, we
could detect only four chemicals in the reference strain Streptomyces griseus subsp. griseus DSM 40236T
as accessory metabolites, which were: fortimicin KK1, capromycin, YO-7625 and halstoctacosanolide B.
It is evident that the identified metabolites may be only a fraction of the total chemical components
in the crude extracts. However, HRLCMS allowed us to have a depiction of the chemical diversity of
both Streptomyces strains under the same analytical conditions.
The major components were determined through the use of HPLC-ELSD. The reference strain,
Streptomyces griseus subsp. griseus DSM 40236T, showed two main components: phenatic acid (RT 12.3
min), and a second one with RT 3.8 min, which could not be identified due to the lack of ionization in
HRLCMS measurement. The major components in the Easter Island strain, Streptomyces sp. SN25_8.1,
were determined as cycloheximide (RT 11.33 min) and actiphenol (RT 15.3 min).
Interestingly, Streptomyces griseus strains are well known for producing the antibiotic streptomycin,
but this molecule was not produced by the strains under our experimental condition. In both
Streptomyces strains, we found chemicals which did not show any match to known Streptomyces
metabolites, suggesting potentially novel molecules. In the case of the Easter Island Streptomyces
strain, we observed that the unknown chemical had a molecular weight of [M+H]+ m/z 579.53381.
This chemical showed a polyprotonation pattern, which points towards a peptide structure. The
reference strain, Streptomyces griseus subsp. griseus DSM 40236T showed an unknown metabolite
with a molecular weight of [M+H]+ m/z 813.59229. The isolation of these compounds from the crude
extracts and chemical analyses would be necessary for structure elucidation.
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3.4. Antibiotic Activity
Antibiotic activity of the two Streptomyces crude extracts (Table 1) were evaluated through
disc diffusion assay, using Gram-positive and Gram-negative bacteria. For the assay, we selected
Staphylococcus lentus DSM 20352 and Escherichia coli DSM 498.
Table 1. Antibiotic activity of crude extracts.
Sample Tested Inhibition Zone (mm)
S. lentus DSM 20352 E. coli DSM 498
Streptomyces sp. SN25_8.1 8 15
Streptomyces griseus subsp. griseus DSM 40236T 8 20
Streptomycin 18 20
As shown in Table 1, the antibiotic activities of the crude extracts of both Streptomyces strains
were quite similar as both produced an inhibition zone with the Gram-positive and the Gram-negative
bacterium. Importantly, the crude extract of the reference strain, Streptomyces griseus subsp. griseus
DSM 40236T, had a stronger inhibitory effect against the Gram-negative bacterium, E. coli, which may
be related to the higher concentrations of its components. The dereplication experiment suggested
the presence of several metabolites with antibiotic activity like 6-beta-deoxy-5-hydroxy-tetracycline,
gancidin W, phenatic acid and netropsin, which may be responsible for the observed antibiotic activity
to both Gram-positive and Gram-negative bacteria. Streptomycin was used as a positive control.
4. Discussion
Much effort is being made for the isolation of new biologically active Streptomyces strains [41],
since this genus has been found to be a reliable source of chemicals with human health application [42].
However, a significant number of new Streptomyces isolates are affiliated through the 16S rRNA
molecular marker to already described species [43], a reason why they are also considered to be
identical in secondary metabolite production.
Recent studies have proposed alternative analyses to determine the dissimilarity of closely related
Streptomyces strains, such as: polyphasic characterization, multilocus sequence typing and full genome
sequencing [19,44], which have shown to be a more precise tool for phylogenic clarification and
secondary metabolite dereplication [45–48]. None of these studies have dealt with the aspect of the
large-scale geographic separation of the Streptomyces strains, which was investigated.
Alternatively, a direct comparison through the laboratory growth of Streptomyces still remains a
more affordable and rapid way of determining how similar the metabolite profiles of the two strains
are. Once grown, the studied Streptomyces can be compared using HRLCMS and 1H NMR techniques,
which vastly help in the dereplication process, since they are quite informative about the chemical
identities and functionalities of the crude extracts.
Our results showed that Streptomyces closely related through the 16S rRNA gene marker presented
differences in macroscopic features (pigmentation, aerial hyphae distribution, colony morphology),
but kept similarities in cell morphology. In terms of secondary metabolite production, we found that
closely related Streptomyces species kept a common set of chemicals, which has been addressed as core
secondary metabolites [49]. This fact is in agreement with the common knowledge that Streptomyces
strains with similar 16S rRNA gene sequences produce identical chemicals [44]. However, our finding
also indicated that Streptomyces strains have a set of accessory secondary metabolites that are unique
for each isolate, despite of the identical 16S rRNA gene sequences. These findings have also been
observed in other Streptomyces species. For example, Antony-Babu et al. [19], developed a polyphasic
analysis of 10 different Streptomyces strains with identical 16S rRNA gene sequences and they found,
that by evaluating characteristic features like halotolerance, optimal pH growth, coloration and GC
content at least 5 out 10 clearly diverged as new species. These results were further supported with a
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multilocus sequence analysis and phylogenetic tree. This study also showed the production of a core
set of secondary metabolites and an accessory chemical diversity.
Another example was provided by Vicente et al. [44], who performed a similar study, but evaluated
the genomes of six closely related Streptomyces strains. The evaluation of the biosynthetic gene clusters
showed that the analyzed Streptomyces strains kept a core set of secondary metabolites and in addition,
a set of strain-specific metabolites. Interestingly, Vicente et al. [44] also reported a set of chemicals
with wide presence in Streptomyces, such as melanin, desferrioxamine B, hopene, isorenieratene and
geosmin. However, none of them could be detected in our experimental work. This observation might
be related with the evolutionary distance between S. griseus strains and the Streptomyces strains used
by Vincente et al. [44]. This last finding may also be an indication of species-specific metabolites.
Interestingly, Vicente et al. [44] also reported chromosome reorganization events (pericentral inversion)
and suggested horizontal gene transfer for the acquisition of biosynthetic gene clusters for strain-specific
secondary metabolites. Finally, this study also conveyed the finding of unknown biosynthetic gene
clusters, suggesting potential for novel chemistry production.
Our data indicated that Streptomyces strains of the same species, isolated from geographical distant
locations, can show important differences in the metabolite profiles. These may be overlooked if
solely a genetic marker such 16S rRNA gene sequence is used as an indicator of secondary metabolite
diversity. As described previously, genome sequencing and comparison, multilocus gene analysis or
growth experiments associated with chemical analysis are three suitable alternatives to dereplicate
closely related Streptomyces strains. This strategy can represent a valuable source of metabolites with
biomedical and industrial application, by preventing the discard of unstudied Streptomyces.
Secondary metabolite production in Streptomyces is not essential for their life cycle, however these
metabolites confer an evolutionary advantage over competitors, since these molecules can be used as a
chemical weapon to control other bacterial and fungal competitors (deterrence, inhibition, decease).
Since Streptomyces can profit from these molecules, Streptomyces might adapt their chemical arsenal in
function of their habitat and their competitors to succeed in new environments.
It remains an open but interesting question, how genes necessary for the production of a particular
secondary metabolite have been gained by individual Streptomyces strains. Different researchers
have discussed this process in other actinobacterial genera, and the most widely accepted hypothesis
is the horizontal transfer of genes (HGT) of entire biosynthetic pathways [50], which may have
direct relation to the environment in which the Streptomyces strains are dwelling. However, gene
duplication, mutation and genetic rearrangement should also not be discarded in the process of
modifying secondary metabolite biosynthetic pathways. The gain and loss of secondary metabolites
may be considered as a biochemical evolution of Streptomyces strains, since the process of selecting
and discarding genes for the production of secondary metabolites may have direct relation to the
environmental competition and survival needs of the strain. It seems reasonable to assume that
phylogenetic almost identical Streptomyces strains may have diverged from a common ancestor because
of their genetic and chemical similarities. Within a sufficient timeframe, Streptomyces strains may have
acquired new biosynthetic abilities to produce different secondary metabolites, because of the need to
adapt and specialize in their particular ecological niche. Environmental pressure may be a driving
force for the retention/discarding/acquisition of the secondary metabolite genes. It has been shown that
Streptomyces strains are capable of spontaneous combination of genetic information [21,51], generating
previously unknown chemical hybrids [52]. However, it is not known for how long these naturally
occurring Streptomyces hybrids have existed in the environment since many factors may influence the
success of the new ecotypes.
5. Conclusions
We established that 16S rRNA gene sequences do not provide information reliable enough to
evaluate the chemodiversity of Streptomyces strains since our analyses of the metabolite profiles showed
differences in the production of secondary metabolites of strains identical on the basis of this genetic
Microorganisms 2019, 7, 166 12 of 15
marker. While we found a core set of secondary metabolites that is identical in both strains, a set of even
more diverse accessory metabolites appear to be strain specific. Based on the phylogenetic closeness
and the similarity of the metabolites, it is suggested that both Streptomyces had a common origin which
went through a subsequent specialization in function of their habitat. In conclusion, this study has
demonstrated that Streptomyces strains, with an identical phylogenetic classification to already known
strains, still represent a diverse and putative source of novel secondary metabolites with potential for
drug discovery; therefore, they should not be discarded in screening processes for bioprospection.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-2607/7/6/166/s1,
Figure S1: 16S rRNA gene sequence alignment of the Streptomyces strains. Supplementary materials also contains
dereplication overview, the individual identification of the molecules, their structures and chemical data, as well
as antibiotic activity of the crude extracts.
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